Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11963961 Combination therapy comprising an ACC inhibitor

Patent 11963961 was granted and assigned to Gilead Sciences on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jamie Geier Bates0

Adrian S. Ray0

Date of Patent

April 23, 2024

0

Patent Application Number

172048350

Date Filed

March 17, 2021

0

Patent Citations

US Patent 10472374 ACC inhibitors and uses thereof

0

US Patent 10980810 Combination therapy comprising an ACC inhibitor

0

US Patent 10487090 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

0

US Patent 8969557 ACC inhibitors and uses thereof

0

US Patent 9139539 FXR (NR1H4) binding and activity modulating compounds

0

US Patent 9453026 ACC inhibitors and uses thereof

0

US Patent 9944655 ACC inhibitors and uses thereof

0

US Patent 10183951 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

0

Patent Primary Examiner

Svetlana M Ivanova

0

CPC Code

0

Patent abstract

The present disclosure provides methods and compositions for treating, stabilizing or lessening the severity or progression of a non-alcoholic fatty liver disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11963961 Combination therapy comprising an ACC inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool